Company intelligence / Profile preview

Prozomix

Haltwhistle, Northumberland, United Kingdom

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Prozomix offers a globally recognized platform for rapid, scalable production and screening of novel biocatalysts, supporting successful applications in discovery and commercial manufacture, especially in pharmaceuticals, APIs, flavors/fragrances, food, and health. Their enzymes and toolkits are widely used by pharma, biotech, and academia, including most major pharmaceutical companies. The company does not directly conduct drug clinical trials, so there are no clinical results in the traditional sense.

Modalities: Recombinant proteinRecombinant proteaseEnzyme
Industry: Non-Drug Biotech

Partnerships

Ginkgo Bioworks

Beyond the preview

Go deeper on Prozomix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prozomix.

Explore the full profile